Full Text of SB1568 103rd General Assembly
SB1568eng 103RD GENERAL ASSEMBLY |
| | SB1568 Engrossed | | LRB103 28639 BMS 55020 b |
|
| 1 | | AN ACT concerning regulation.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 5. The Illinois Insurance Code is amended by | 5 | | changing Section 370c.1 as follows: | 6 | | (215 ILCS 5/370c.1) | 7 | | Sec. 370c.1. Mental, emotional, nervous, or substance use | 8 | | disorder or condition parity. | 9 | | (a) On and after July 23, 2021 (the effective date of | 10 | | Public Act 102-135), every insurer that amends, delivers, | 11 | | issues, or renews a group or individual policy of accident and | 12 | | health insurance or a qualified health plan offered through | 13 | | the Health Insurance Marketplace in this State providing | 14 | | coverage for hospital or medical treatment and for the | 15 | | treatment of mental, emotional, nervous, or substance use | 16 | | disorders or conditions shall ensure prior to policy issuance | 17 | | that: | 18 | | (1) the financial requirements applicable to such | 19 | | mental, emotional, nervous, or substance use disorder or | 20 | | condition benefits are no more restrictive than the | 21 | | predominant financial requirements applied to | 22 | | substantially all hospital and medical benefits covered by | 23 | | the policy and that there are no separate cost-sharing |
| | | SB1568 Engrossed | - 2 - | LRB103 28639 BMS 55020 b |
|
| 1 | | requirements that are applicable only with respect to | 2 | | mental, emotional, nervous, or substance use disorder or | 3 | | condition benefits; and | 4 | | (2) the treatment limitations applicable to such | 5 | | mental, emotional, nervous, or substance use disorder or | 6 | | condition benefits are no more restrictive than the | 7 | | predominant treatment limitations applied to substantially | 8 | | all hospital and medical benefits covered by the policy | 9 | | and that there are no separate treatment limitations that | 10 | | are applicable only with respect to mental, emotional, | 11 | | nervous, or substance use disorder or condition benefits. | 12 | | (b) The following provisions shall apply concerning | 13 | | aggregate lifetime limits: | 14 | | (1) In the case of a group or individual policy of | 15 | | accident and health insurance or a qualified health plan | 16 | | offered through the Health Insurance Marketplace amended, | 17 | | delivered, issued, or renewed in this State on or after | 18 | | September 9, 2015 (the effective date of Public Act | 19 | | 99-480) that provides coverage for hospital or medical | 20 | | treatment and for the treatment of mental, emotional, | 21 | | nervous, or substance use disorders or conditions the | 22 | | following provisions shall apply: | 23 | | (A) if the policy does not include an aggregate | 24 | | lifetime limit on substantially all hospital and | 25 | | medical benefits, then the policy may not impose any | 26 | | aggregate lifetime limit on mental, emotional, |
| | | SB1568 Engrossed | - 3 - | LRB103 28639 BMS 55020 b |
|
| 1 | | nervous, or substance use disorder or condition | 2 | | benefits; or | 3 | | (B) if the policy includes an aggregate lifetime | 4 | | limit on substantially all hospital and medical | 5 | | benefits (in this subsection referred to as the | 6 | | "applicable lifetime limit"), then the policy shall | 7 | | either: | 8 | | (i) apply the applicable lifetime limit both | 9 | | to the hospital and medical benefits to which it | 10 | | otherwise would apply and to mental, emotional, | 11 | | nervous, or substance use disorder or condition | 12 | | benefits and not distinguish in the application of | 13 | | the limit between the hospital and medical | 14 | | benefits and mental, emotional, nervous, or | 15 | | substance use disorder or condition benefits; or | 16 | | (ii) not include any aggregate lifetime limit | 17 | | on mental, emotional, nervous, or substance use | 18 | | disorder or condition benefits that is less than | 19 | | the applicable lifetime limit. | 20 | | (2) In the case of a policy that is not described in | 21 | | paragraph (1) of subsection (b) of this Section and that | 22 | | includes no or different aggregate lifetime limits on | 23 | | different categories of hospital and medical benefits, the | 24 | | Director shall establish rules under which subparagraph | 25 | | (B) of paragraph (1) of subsection (b) of this Section is | 26 | | applied to such policy with respect to mental, emotional, |
| | | SB1568 Engrossed | - 4 - | LRB103 28639 BMS 55020 b |
|
| 1 | | nervous, or substance use disorder or condition benefits | 2 | | by substituting for the applicable lifetime limit an | 3 | | average aggregate lifetime limit that is computed taking | 4 | | into account the weighted average of the aggregate | 5 | | lifetime limits applicable to such categories. | 6 | | (c) The following provisions shall apply concerning annual | 7 | | limits: | 8 | | (1) In the case of a group or individual policy of | 9 | | accident and health insurance or a qualified health plan | 10 | | offered through the Health Insurance Marketplace amended, | 11 | | delivered, issued, or renewed in this State on or after | 12 | | September 9, 2015 (the effective date of Public Act | 13 | | 99-480) that provides coverage for hospital or medical | 14 | | treatment and for the treatment of mental, emotional, | 15 | | nervous, or substance use disorders or conditions the | 16 | | following provisions shall apply: | 17 | | (A) if the policy does not include an annual limit | 18 | | on substantially all hospital and medical benefits, | 19 | | then the policy may not impose any annual limits on | 20 | | mental, emotional, nervous, or substance use disorder | 21 | | or condition benefits; or | 22 | | (B) if the policy includes an annual limit on | 23 | | substantially all hospital and medical benefits (in | 24 | | this subsection referred to as the "applicable annual | 25 | | limit"), then the policy shall either: | 26 | | (i) apply the applicable annual limit both to |
| | | SB1568 Engrossed | - 5 - | LRB103 28639 BMS 55020 b |
|
| 1 | | the hospital and medical benefits to which it | 2 | | otherwise would apply and to mental, emotional, | 3 | | nervous, or substance use disorder or condition | 4 | | benefits and not distinguish in the application of | 5 | | the limit between the hospital and medical | 6 | | benefits and mental, emotional, nervous, or | 7 | | substance use disorder or condition benefits; or | 8 | | (ii) not include any annual limit on mental, | 9 | | emotional, nervous, or substance use disorder or | 10 | | condition benefits that is less than the | 11 | | applicable annual limit. | 12 | | (2) In the case of a policy that is not described in | 13 | | paragraph (1) of subsection (c) of this Section and that | 14 | | includes no or different annual limits on different | 15 | | categories of hospital and medical benefits, the Director | 16 | | shall establish rules under which subparagraph (B) of | 17 | | paragraph (1) of subsection (c) of this Section is applied | 18 | | to such policy with respect to mental, emotional, nervous, | 19 | | or substance use disorder or condition benefits by | 20 | | substituting for the applicable annual limit an average | 21 | | annual limit that is computed taking into account the | 22 | | weighted average of the annual limits applicable to such | 23 | | categories. | 24 | | (d) With respect to mental, emotional, nervous, or | 25 | | substance use disorders or conditions, an insurer shall use | 26 | | policies and procedures for the election and placement of |
| | | SB1568 Engrossed | - 6 - | LRB103 28639 BMS 55020 b |
|
| 1 | | mental, emotional, nervous, or substance use disorder or | 2 | | condition treatment drugs on their formulary that are no less | 3 | | favorable to the insured as those policies and procedures the | 4 | | insurer uses for the selection and placement of drugs for | 5 | | medical or surgical conditions and shall follow the expedited | 6 | | coverage determination requirements for substance abuse | 7 | | treatment drugs set forth in Section 45.2 of the Managed Care | 8 | | Reform and Patient Rights Act. | 9 | | (e) This Section shall be interpreted in a manner | 10 | | consistent with all applicable federal parity regulations | 11 | | including, but not limited to, the Paul Wellstone and Pete | 12 | | Domenici Mental Health Parity and Addiction Equity Act of | 13 | | 2008, final regulations issued under the Paul Wellstone and | 14 | | Pete Domenici Mental Health Parity and Addiction Equity Act of | 15 | | 2008 and final regulations applying the Paul Wellstone and | 16 | | Pete Domenici Mental Health Parity and Addiction Equity Act of | 17 | | 2008 to Medicaid managed care organizations, the Children's | 18 | | Health Insurance Program, and alternative benefit plans. | 19 | | (f) The provisions of subsections (b) and (c) of this | 20 | | Section shall not be interpreted to allow the use of lifetime | 21 | | or annual limits otherwise prohibited by State or federal law. | 22 | | (g) As used in this Section: | 23 | | "Financial requirement" includes deductibles, copayments, | 24 | | coinsurance, and out-of-pocket maximums, but does not include | 25 | | an aggregate lifetime limit or an annual limit subject to | 26 | | subsections (b) and (c). |
| | | SB1568 Engrossed | - 7 - | LRB103 28639 BMS 55020 b |
|
| 1 | | "Mental, emotional, nervous, or substance use disorder or | 2 | | condition" means a condition or disorder that involves a | 3 | | mental health condition or substance use disorder that falls | 4 | | under any of the diagnostic categories listed in the mental | 5 | | and behavioral disorders chapter of the current edition of the | 6 | | International Classification of Disease or that is listed in | 7 | | the most recent version of the Diagnostic and Statistical | 8 | | Manual of Mental Disorders. | 9 | | "Treatment limitation" includes limits on benefits based | 10 | | on the frequency of treatment, number of visits, days of | 11 | | coverage, days in a waiting period, or other similar limits on | 12 | | the scope or duration of treatment. "Treatment limitation" | 13 | | includes both quantitative treatment limitations, which are | 14 | | expressed numerically (such as 50 outpatient visits per year), | 15 | | and nonquantitative treatment limitations, which otherwise | 16 | | limit the scope or duration of treatment. A permanent | 17 | | exclusion of all benefits for a particular condition or | 18 | | disorder shall not be considered a treatment limitation. | 19 | | "Nonquantitative treatment" means those limitations as | 20 | | described under federal regulations (26 CFR 54.9812-1). | 21 | | "Nonquantitative treatment limitations" include, but are not | 22 | | limited to, those limitations described under federal | 23 | | regulations 26 CFR 54.9812-1, 29 CFR 2590.712, and 45 CFR | 24 | | 146.136.
| 25 | | (h) The Department of Insurance shall implement the | 26 | | following education initiatives: |
| | | SB1568 Engrossed | - 8 - | LRB103 28639 BMS 55020 b |
|
| 1 | | (1) By January 1, 2016, the Department shall develop a | 2 | | plan for a Consumer Education Campaign on parity. The | 3 | | Consumer Education Campaign shall focus its efforts | 4 | | throughout the State and include trainings in the | 5 | | northern, southern, and central regions of the State, as | 6 | | defined by the Department, as well as each of the 5 managed | 7 | | care regions of the State as identified by the Department | 8 | | of Healthcare and Family Services. Under this Consumer | 9 | | Education Campaign, the Department shall: (1) by January | 10 | | 1, 2017, provide at least one live training in each region | 11 | | on parity for consumers and providers and one webinar | 12 | | training to be posted on the Department website and (2) | 13 | | establish a consumer hotline to assist consumers in | 14 | | navigating the parity process by March 1, 2017. By January | 15 | | 1, 2018 the Department shall issue a report to the General | 16 | | Assembly on the success of the Consumer Education | 17 | | Campaign, which shall indicate whether additional training | 18 | | is necessary or would be recommended. | 19 | | (2) The Department, in coordination with the | 20 | | Department of Human Services and the Department of | 21 | | Healthcare and Family Services, shall convene a working | 22 | | group of health care insurance carriers, mental health | 23 | | advocacy groups, substance abuse patient advocacy groups, | 24 | | and mental health physician groups for the purpose of | 25 | | discussing issues related to the treatment and coverage of | 26 | | mental, emotional, nervous, or substance use disorders or |
| | | SB1568 Engrossed | - 9 - | LRB103 28639 BMS 55020 b |
|
| 1 | | conditions and compliance with parity obligations under | 2 | | State and federal law. Compliance shall be measured, | 3 | | tracked, and shared during the meetings of the working | 4 | | group. The working group shall meet once before January 1, | 5 | | 2016 and shall meet semiannually thereafter. The | 6 | | Department shall issue an annual report to the General | 7 | | Assembly that includes a list of the health care insurance | 8 | | carriers, mental health advocacy groups, substance abuse | 9 | | patient advocacy groups, and mental health physician | 10 | | groups that participated in the working group meetings, | 11 | | details on the issues and topics covered, and any | 12 | | legislative recommendations developed by the working | 13 | | group. | 14 | | (3) Not later than January 1 of each year, the | 15 | | Department, in conjunction with the Department of | 16 | | Healthcare and Family Services, shall issue a joint report | 17 | | to the General Assembly and provide an educational | 18 | | presentation to the General Assembly. The report and | 19 | | presentation shall: | 20 | | (A) Cover the methodology the Departments use to | 21 | | check for compliance with the federal Paul Wellstone | 22 | | and Pete Domenici Mental Health Parity and Addiction | 23 | | Equity Act of 2008, 42 U.S.C. 18031(j), and any | 24 | | federal regulations or guidance relating to the | 25 | | compliance and oversight of the federal Paul Wellstone | 26 | | and Pete Domenici Mental Health Parity and Addiction |
| | | SB1568 Engrossed | - 10 - | LRB103 28639 BMS 55020 b |
|
| 1 | | Equity Act of 2008 and 42 U.S.C. 18031(j). | 2 | | (B) Cover the methodology the Departments use to | 3 | | check for compliance with this Section and Sections | 4 | | 356z.23 and 370c of this Code. | 5 | | (C) Identify market conduct examinations or, in | 6 | | the case of the Department of Healthcare and Family | 7 | | Services, audits conducted or completed during the | 8 | | preceding 12-month period regarding compliance with | 9 | | parity in mental, emotional, nervous, and substance | 10 | | use disorder or condition benefits under State and | 11 | | federal laws and summarize the results of such market | 12 | | conduct examinations and audits. This shall include: | 13 | | (i) the number of market conduct examinations | 14 | | and audits initiated and completed; | 15 | | (ii) the benefit classifications examined by | 16 | | each market conduct examination and audit; | 17 | | (iii) the subject matter of each market | 18 | | conduct examination and audit, including | 19 | | quantitative and nonquantitative treatment | 20 | | limitations; and | 21 | | (iv) a summary of the basis for the final | 22 | | decision rendered in each market conduct | 23 | | examination and audit. | 24 | | Individually identifiable information shall be | 25 | | excluded from the reports consistent with federal | 26 | | privacy protections. |
| | | SB1568 Engrossed | - 11 - | LRB103 28639 BMS 55020 b |
|
| 1 | | (D) Detail any educational or corrective actions | 2 | | the Departments have taken to ensure compliance with | 3 | | the federal Paul Wellstone and Pete Domenici Mental | 4 | | Health Parity and Addiction Equity Act of 2008, 42 | 5 | | U.S.C. 18031(j), this Section, and Sections 356z.23 | 6 | | and 370c of this Code. | 7 | | (E) The report must be written in non-technical, | 8 | | readily understandable language and shall be made | 9 | | available to the public by, among such other means as | 10 | | the Departments find appropriate, posting the report | 11 | | on the Departments' websites. | 12 | | (i) The Parity Advancement Fund is created as a special | 13 | | fund in the State treasury. Moneys from fines and penalties | 14 | | collected from insurers for violations of this Section shall | 15 | | be deposited into the Fund. Moneys deposited into the Fund for | 16 | | appropriation by the General Assembly to the Department shall | 17 | | be used for the purpose of providing financial support of the | 18 | | Consumer Education Campaign, parity compliance advocacy, and | 19 | | other initiatives that support parity implementation and | 20 | | enforcement on behalf of consumers. | 21 | | (j) The Department of Insurance and the Department of | 22 | | Healthcare and Family Services shall convene and provide | 23 | | technical support to a workgroup of 11 members that shall be | 24 | | comprised of 3 mental health parity experts recommended by an | 25 | | organization advocating on behalf of mental health parity | 26 | | appointed by the President of the Senate; 3 behavioral health |
| | | SB1568 Engrossed | - 12 - | LRB103 28639 BMS 55020 b |
|
| 1 | | providers recommended by an organization that represents | 2 | | behavioral health providers appointed by the Speaker of the | 3 | | House of Representatives; 2 representing Medicaid managed care | 4 | | organizations recommended by an organization that represents | 5 | | Medicaid managed care plans appointed by the Minority Leader | 6 | | of the House of Representatives; 2 representing commercial | 7 | | insurers recommended by an organization that represents | 8 | | insurers appointed by the Minority Leader of the Senate; and a | 9 | | representative of an organization that represents Medicaid | 10 | | managed care plans appointed by the Governor. | 11 | | The workgroup shall provide recommendations to the General | 12 | | Assembly on health plan data reporting requirements that | 13 | | separately break out data on mental, emotional, nervous, or | 14 | | substance use disorder or condition benefits and data on other | 15 | | medical benefits, including physical health and related health | 16 | | services no later than December 31, 2019. The recommendations | 17 | | to the General Assembly shall be filed with the Clerk of the | 18 | | House of Representatives and the Secretary of the Senate in | 19 | | electronic form only, in the manner that the Clerk and the | 20 | | Secretary shall direct. This workgroup shall take into account | 21 | | federal requirements and recommendations on mental health | 22 | | parity reporting for the Medicaid program. This workgroup | 23 | | shall also develop the format and provide any needed | 24 | | definitions for reporting requirements in subsection (k). The | 25 | | research and evaluation of the working group shall include, | 26 | | but not be limited to: |
| | | SB1568 Engrossed | - 13 - | LRB103 28639 BMS 55020 b |
|
| 1 | | (1) claims denials due to benefit limits, if | 2 | | applicable; | 3 | | (2) administrative denials for no prior authorization; | 4 | | (3) denials due to not meeting medical necessity; | 5 | | (4) denials that went to external review and whether | 6 | | they were upheld or overturned for medical necessity; | 7 | | (5) out-of-network claims; | 8 | | (6) emergency care claims; | 9 | | (7) network directory providers in the outpatient | 10 | | benefits classification who filed no claims in the last 6 | 11 | | months, if applicable; | 12 | | (8) the impact of existing and pertinent limitations | 13 | | and restrictions related to approved services, licensed | 14 | | providers, reimbursement levels, and reimbursement | 15 | | methodologies within the Division of Mental Health, the | 16 | | Division of Substance Use Prevention and Recovery | 17 | | programs, the Department of Healthcare and Family | 18 | | Services, and, to the extent possible, federal regulations | 19 | | and law; and | 20 | | (9) when reporting and publishing should begin. | 21 | | Representatives from the Department of Healthcare and | 22 | | Family Services, representatives from the Division of Mental | 23 | | Health, and representatives from the Division of Substance Use | 24 | | Prevention and Recovery shall provide technical advice to the | 25 | | workgroup. | 26 | | (j-5) The Department of Insurance shall collect the |
| | | SB1568 Engrossed | - 14 - | LRB103 28639 BMS 55020 b |
|
| 1 | | following information: | 2 | | (1) The number of employment disability insurance | 3 | | plans offered in this State, including, but not limited | 4 | | to: | 5 | | (A) individual short-term policies; | 6 | | (B) individual long-term policies; | 7 | | (C) group short-term policies; and | 8 | | (D) group long-term policies. | 9 | | (2) The number of policies referenced in paragraph (1) | 10 | | of this subsection that limit mental health and substance | 11 | | use disorder benefits. | 12 | | (3) The average defined benefit period for the | 13 | | policies referenced in paragraph (1) of this subsection, | 14 | | both for those policies that limit and those policies that | 15 | | have no limitation on mental health and substance use | 16 | | disorder benefits. | 17 | | (4) Whether the policies referenced in paragraph (1) | 18 | | of this subsection are purchased on a voluntary or | 19 | | non-voluntary basis. | 20 | | (5) The identities of the individuals, entities, or a | 21 | | combination of the 2, that assume the cost associated with | 22 | | covering the policies referenced in paragraph (1) of this | 23 | | subsection. | 24 | | (6) The average defined benefit period for plans that | 25 | | cover physical disability and mental health and substance | 26 | | abuse without limitation, including, but not limited to: |
| | | SB1568 Engrossed | - 15 - | LRB103 28639 BMS 55020 b |
|
| 1 | | (A) individual short-term policies; | 2 | | (B) individual long-term policies; | 3 | | (C) group short-term policies; and | 4 | | (D) group long-term policies. | 5 | | (7) The average premiums for disability income | 6 | | insurance issued in this State for: | 7 | | (A) individual short-term policies that limit | 8 | | mental health and substance use disorder benefits; | 9 | | (B) individual long-term policies that limit | 10 | | mental health and substance use disorder benefits; | 11 | | (C) group short-term policies that limit mental | 12 | | health and substance use disorder benefits; | 13 | | (D) group long-term policies that limit mental | 14 | | health and substance use disorder benefits; | 15 | | (E) individual short-term policies that include | 16 | | mental health and substance use disorder benefits | 17 | | without limitation; | 18 | | (F) individual long-term policies that include | 19 | | mental health and substance use disorder benefits | 20 | | without limitation; | 21 | | (G) group short-term policies that include mental | 22 | | health and substance use disorder benefits without | 23 | | limitation; and | 24 | | (H) group long-term policies that include mental | 25 | | health and substance use disorder benefits without | 26 | | limitation. |
| | | SB1568 Engrossed | - 16 - | LRB103 28639 BMS 55020 b |
|
| 1 | | The Department shall present its findings regarding | 2 | | information collected under this subsection (j-5) to the | 3 | | General Assembly no later than April 30, 2024. Information | 4 | | regarding a specific insurance provider's contributions to the | 5 | | Department's report shall be exempt from disclosure under | 6 | | paragraph (t) of subsection (1) of Section 7 of the Freedom of | 7 | | Information Act. The aggregated information gathered by the | 8 | | Department shall not be exempt from disclosure under paragraph | 9 | | (t) of subsection (1) of Section 7 of the Freedom of | 10 | | Information Act. | 11 | | (k) An insurer that amends, delivers, issues, or renews a | 12 | | group or individual policy of accident and health insurance or | 13 | | a qualified health plan offered through the health insurance | 14 | | marketplace in this State providing coverage for hospital or | 15 | | medical treatment and for the treatment of mental, emotional, | 16 | | nervous, or substance use disorders or conditions shall submit | 17 | | an annual report, the format and definitions for which will be | 18 | | developed by the workgroup in subsection (j), to the | 19 | | Department, or, with respect to medical assistance, the | 20 | | Department of Healthcare and Family Services starting on or | 21 | | before July 1, 2020 that contains the following information | 22 | | separately for inpatient in-network benefits, inpatient | 23 | | out-of-network benefits, outpatient in-network benefits, | 24 | | outpatient out-of-network benefits, emergency care benefits, | 25 | | and prescription drug benefits in the case of accident and | 26 | | health insurance or qualified health plans, or inpatient, |
| | | SB1568 Engrossed | - 17 - | LRB103 28639 BMS 55020 b |
|
| 1 | | outpatient, emergency care, and prescription drug benefits in | 2 | | the case of medical assistance: | 3 | | (1) A summary of the plan's pharmacy management | 4 | | processes for mental, emotional, nervous, or substance use | 5 | | disorder or condition benefits compared to those for other | 6 | | medical benefits. | 7 | | (2) A summary of the internal processes of review for | 8 | | experimental benefits and unproven technology for mental, | 9 | | emotional, nervous, or substance use disorder or condition | 10 | | benefits and those for
other medical benefits. | 11 | | (3) A summary of how the plan's policies and | 12 | | procedures for utilization management for mental, | 13 | | emotional, nervous, or substance use disorder or condition | 14 | | benefits compare to those for other medical benefits. | 15 | | (4) A description of the process used to develop or | 16 | | select the medical necessity criteria for mental, | 17 | | emotional, nervous, or substance use disorder or condition | 18 | | benefits and the process used to develop or select the | 19 | | medical necessity criteria for medical and surgical | 20 | | benefits. | 21 | | (5) Identification of all nonquantitative treatment | 22 | | limitations that are applied to both mental, emotional, | 23 | | nervous, or substance use disorder or condition benefits | 24 | | and medical and surgical benefits within each | 25 | | classification of benefits. | 26 | | (6) The results of an analysis that demonstrates that |
| | | SB1568 Engrossed | - 18 - | LRB103 28639 BMS 55020 b |
|
| 1 | | for the medical necessity criteria described in | 2 | | subparagraph (A) and for each nonquantitative treatment | 3 | | limitation identified in subparagraph (B), as written and | 4 | | in operation, the processes, strategies, evidentiary | 5 | | standards, or other factors used in applying the medical | 6 | | necessity criteria and each nonquantitative treatment | 7 | | limitation to mental, emotional, nervous, or substance use | 8 | | disorder or condition benefits within each classification | 9 | | of benefits are comparable to, and are applied no more | 10 | | stringently than, the processes, strategies, evidentiary | 11 | | standards, or other factors used in applying the medical | 12 | | necessity criteria and each nonquantitative treatment | 13 | | limitation to medical and surgical benefits within the | 14 | | corresponding classification of benefits; at a minimum, | 15 | | the results of the analysis shall: | 16 | | (A) identify the factors used to determine that a | 17 | | nonquantitative treatment limitation applies to a | 18 | | benefit, including factors that were considered but | 19 | | rejected; | 20 | | (B) identify and define the specific evidentiary | 21 | | standards used to define the factors and any other | 22 | | evidence relied upon in designing each nonquantitative | 23 | | treatment limitation; | 24 | | (C) provide the comparative analyses, including | 25 | | the results of the analyses, performed to determine | 26 | | that the processes and strategies used to design each |
| | | SB1568 Engrossed | - 19 - | LRB103 28639 BMS 55020 b |
|
| 1 | | nonquantitative treatment limitation, as written, for | 2 | | mental, emotional, nervous, or substance use disorder | 3 | | or condition benefits are comparable to, and are | 4 | | applied no more stringently than, the processes and | 5 | | strategies used to design each nonquantitative | 6 | | treatment limitation, as written, for medical and | 7 | | surgical benefits; | 8 | | (D) provide the comparative analyses, including | 9 | | the results of the analyses, performed to determine | 10 | | that the processes and strategies used to apply each | 11 | | nonquantitative treatment limitation, in operation, | 12 | | for mental, emotional, nervous, or substance use | 13 | | disorder or condition benefits are comparable to, and | 14 | | applied no more stringently than, the processes or | 15 | | strategies used to apply each nonquantitative | 16 | | treatment limitation, in operation, for medical and | 17 | | surgical benefits; and | 18 | | (E) disclose the specific findings and conclusions | 19 | | reached by the insurer that the results of the | 20 | | analyses described in subparagraphs (C) and (D) | 21 | | indicate that the insurer is in compliance with this | 22 | | Section and the Mental Health Parity and Addiction | 23 | | Equity Act of 2008 and its implementing regulations, | 24 | | which includes 42 CFR Parts 438, 440, and 457 and 45 | 25 | | CFR 146.136 and any other related federal regulations | 26 | | found in the Code of Federal Regulations. |
| | | SB1568 Engrossed | - 20 - | LRB103 28639 BMS 55020 b |
|
| 1 | | (7) Any other information necessary to clarify data | 2 | | provided in accordance with this Section requested by the | 3 | | Director, including information that may be proprietary or | 4 | | have commercial value, under the requirements of Section | 5 | | 30 of the Viatical Settlements Act of 2009. | 6 | | (l) An insurer that amends, delivers, issues, or renews a | 7 | | group or individual policy of accident and health insurance or | 8 | | a qualified health plan offered through the health insurance | 9 | | marketplace in this State providing coverage for hospital or | 10 | | medical treatment and for the treatment of mental, emotional, | 11 | | nervous, or substance use disorders or conditions on or after | 12 | | January 1, 2019 (the effective date of Public Act 100-1024) | 13 | | shall, in advance of the plan year, make available to the | 14 | | Department or, with respect to medical assistance, the | 15 | | Department of Healthcare and Family Services and to all plan | 16 | | participants and beneficiaries the information required in | 17 | | subparagraphs (C) through (E) of paragraph (6) of subsection | 18 | | (k). For plan participants and medical assistance | 19 | | beneficiaries, the information required in subparagraphs (C) | 20 | | through (E) of paragraph (6) of subsection (k) shall be made | 21 | | available on a publicly-available website whose web address is | 22 | | prominently displayed in plan and managed care organization | 23 | | informational and marketing materials. | 24 | | (m) In conjunction with its compliance examination program | 25 | | conducted in accordance with the Illinois State Auditing Act, | 26 | | the Auditor General shall undertake a review of
compliance by |
| | | SB1568 Engrossed | - 21 - | LRB103 28639 BMS 55020 b |
|
| 1 | | the Department and the Department of Healthcare and Family | 2 | | Services with Section 370c and this Section. Any
findings | 3 | | resulting from the review conducted under this Section shall | 4 | | be included in the applicable State agency's compliance | 5 | | examination report. Each compliance examination report shall | 6 | | be issued in accordance with Section 3-14 of the Illinois | 7 | | State
Auditing Act. A copy of each report shall also be | 8 | | delivered to
the head of the applicable State agency and | 9 | | posted on the Auditor General's website. | 10 | | (Source: P.A. 102-135, eff. 7-23-21; 102-579, eff. 8-25-21; | 11 | | 102-813, eff. 5-13-22.)
|
|